Reuters logo
BRIEF-‍Shire Pharma Canada says its Onivyde has ‍received approval in Canada
August 11, 2017 / 12:17 PM / 3 months ago

BRIEF-‍Shire Pharma Canada says its Onivyde has ‍received approval in Canada

Aug 11 (Reuters) - Shire Plc

* ‍Shire Pharma Canada says its ‍Onivyde has ‍received approval in Canada for treatment of Metastatic Adenocarcinoma of Pancreas in Post-Gemcitabine setting

* Shire Pharma Canada says Onivyde approved in combination with 5-Fluorouracil and Leucovorin ‍​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below